Subscribe to thousands of academic journals for just $40/month
Read and share the articles you need for your research, all in one place.

Effect of Fenofibrate on Serum Inflammatory Markers in Patients With High Triglyceride Values

Details

Publisher
Sage Publications
Copyright
Copyright © 2004 by SAGE Publications
ISSN
1074-2484
eISSN
1074-2484
D.O.I.
10.1177/107424840400900i105
Publisher site
See Article on Publisher Site

Preview Only

Expand Tray Hide Tray

Effect of Fenofibrate on Serum Inflammatory Markers in Patients With High Triglyceride Values

Abstract

Background: Atherosclerosis is the leading cause of death in developed countries. Although the mechanisms that underlie this process are not well defined, it has been proposed that atherosclerosis is mainly an inflammatory disease. In this context, a number of inflammatory markers have been studied for their ability to predict future cardiovascular events in asymptomatic individuals or patients with established atherosclerotic disease. Methods and Results: The aim of our study was to evaluate the effect of micronized fenofibrate on serum inflammatory markers, such as C-reactive protein, fibrinogen, and plasma platelet-activating factor acetylhydrolase (PAF-AH) in patients with high triglyceride values. An analysis of baseline values revealed that hypertriglyceridemic patients (n = 58) exhibit an atherogenic phenotype, characterized not only by elevated lipid values but also by high concentrations of serum inflammatory markers. Along with the improvement in serum lipid profile (reduction in triglycerides and total cholesterol, low-density lipoprotein, and nonhigh-density lipoprotein-cholesterol, with a concomitant increase in high-density lipoprotein-cholesterol levels), fenofibrate administration significantly reduced the values of serum inflammatory markers by 34%, 9.5%, and 24.8% for C-reactive protein, fibrinogen, and plasma PAF-AH, respectively. However, with the exception of PAF-AH, these reductions in inflammatory markers were not correlated with the changes in lipid values. Conclusions: In addition to its well-known hypolipidemic effects, fenofibrate may also possess significant anti-inflammatory properties that can contribute its antiatherogenic effect.
Loading next page...

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.

 
/lp/sage/effect-of-fenofibrate-on-serum-inflammatory-markers-in-patients-with-I5R1XxUk1r